SynthesisJournal of cellular and molecular medicine2022

Effects of SGLT2 inhibitors on haematocrit and haemoglobin levels and the associated cardiorenal benefits in T2DM patients: A meta-analysis.

Qi Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.